A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

Clinical trial NCT07143448 · RECRUITING

Trial details

NCT number: NCT07143448
Sponsor: 35Pharma Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2026-08-01
Primary completion: 2028-03-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.